Patrik Eriksson Net Worth

The estimated Net Worth of Patrik Eriksson is at least $2.42 Milione dollars as of 20 September 2019. Mr. Eriksson owns over 5,000 units of Envista Corp stock worth over $88,200 and over the last 5 years he sold NVST stock worth over $0. In addition, he makes $2,331,340 as Senior Vice President at Envista Corp.

Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!

Sign up

Already have an account? Sign in

Mr. Eriksson NVST stock SEC Form 4 insiders trading

Patrik has made over 1 trades of the Envista Corp stock since 2019, according to the Form 4 filled with the SEC. Most recently he bought 5,000 units of NVST stock worth $110,000 on 20 September 2019.

The largest trade he's ever made was buying 5,000 units of Envista Corp stock on 20 September 2019 worth over $110,000. On average, Patrik trades about 417 units every 0 days since 2019. As of 20 September 2019 he still owns at least 5,000 units of Envista Corp stock.

You can see the complete history of Mr. Eriksson stock trades at the bottom of the page.

Patrik Eriksson biography

Patrik Eriksson serves as Senior Vice President of the Company since September 2019 and as President of the Nobel Biocare business since January 2020. Prior to that, Mr. Eriksson served in various leadership roles for Danaher’s Dental business since October 2012, including as President of the KaVo Kerr business from January 2018 until January 2020 and President of the Ormco business from January 2014 to December 2017.

What is the salary of Patrik Eriksson?

As the Senior Vice President of Envista Corp, the total compensation of Patrik Eriksson at Envista Corp is $2,331,340. There are 2 executives at Envista Corp getting paid more, with Amir Aghdaei having the highest compensation of $7,377,910.

How old is Patrik Eriksson?

Patrik Eriksson is 52, he's been the Senior Vice President of Envista Corp since 2019. There are 12 older and 7 younger executives at Envista Corp. The oldest executive at Envista Holdings Corp is Amir Aghdaei, 62, who is the President, Chief Executive Officer, Director.

What's Patrik Eriksson's mailing address?

Patrik's mailing address filed with the SEC is C/O ENVISTA HOLDINGS CORPORATION, 200 S. KRAEMER BLVD., BLDG. E, BREA, CA, 92821.

Insiders trading at Envista Corp

Over the last 5 years, insiders at Envista Corp have traded over $35,099,063 worth of Envista Corp stock and bought 101,717 units worth $1,939,832 . The most active insiders traders include Corp /De/ Danaher, Vivek Jain e Wendy Carruthers. On average, Envista Corp executives and independent directors trade stock every 31 days with the average trade being worth of $320,413. The most recent stock trade was executed by Paul A Keel on 13 August 2024, trading 30,000 units of NVST stock currently worth $506,100.

What does Envista Corp do?

we know that dental professionals do more than create healthy, beautiful smiles—they create confidence. to achieve their goals, they need a champion. they need someone who will be there for them, side by side and end to end. at envista, we are uniquely positioned to be this champion. our differentiated combination of continuous improvement, a bias toward action and innovation, and a deep respect for the professionals we serve embolden us to champion dental professionals like no one else can. our comprehensive product portfolio covers an estimated 90% of dentists’ clinical needs for diagnosing, treating and preventing dental conditions as well as improving the aesthetics of the human smile. we believe true champions lift each other up, and we are looking for new champions to join our team. if you believe, champions do more than win, they stand for something bigger, you can build a meaningful career at envista. if you believe champions work to be their best, help others be theirs, sho

Complete history of Mr. Eriksson stock trades at Envista Corp

Envista Corp executives and stock owners

Envista Corp executives and other stock owners filed with the SEC include:

• Amir Aghdaei,
  President, Chief Executive Officer, Director
• Amir Aghdaei,
  Pres, CEO & Director
• Patrik Eriksson,
  Senior Vice President
• Curt Bludworth,
  Chief Human Resource Officer, Senior Vice President
• Howard Yu,
  Chief Financial Officer, Senior Vice President
• Patrik Eriksson,
  Sr. VP & Pres of Nobel Biocare
• Howard H. Yu,
  Sr. VP & CFO
• Mark E. Nance,
  Sr. VP, Gen. Counsel & Sec.
• Jean-Claude E. Kyrillos,
  Sr. VP and Pres of Imaging & DTX
• Scott Huennekens,
  Independent Chairman of the Board
• Christine Tsingos,
  Independent Director
• Wendy Carruthers,
  Independent Director
• Kieran Gallahue,
  Independent Director
• Daniel Raskas,
  Director
• John Bedford,
  Vice President - Investor Relations
• Gayle Sheppard,
  Independent Director
• Vivek Jain,
  Independent Director
• Mischa Reis,
  Senior Vice President - Strategy and Corporate Development
• Jean-Claude Kyrillos,
  Senior Vice President and President of the KaVo Kerr Business
• Jeffrey Kappler,
  Senior Vice President
• Mark Nance,
  Senior Vice President, General Counsel, Secretary
• Curt W. Bludworth,
  Sr. VP & Chief HR Officer
• Mischa M. Reis,
  Sr. VP of Strategy & Corp. Devel.
• Juan Arbona,
  Chief Compliance Officer
• John C. Moten,
  VP of Investor Relations
• Kari-Lyn Moore,
  VP & Chief Accounting Officer
• Robert Befidi,
  President, Diagnostics
• Paul A Keel,
  Chief Executive Officer
• Corp /De/ Danaher,
  10% owner
• William K Daniel,
  Director
• Hans Geiselhoeringer,
  SENIOR VICE PRESIDENT
• Eric Conley,
  SVP, Orthodontics
• Barbara B. Hulit,
  Director
• Stephen Keller,
  Principal Financial Officer
• Faez C Kaabi,
  Chief Accounting Officer
• Eric D. Hammes,
  Chief Financial Officer